Cargando…

24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome

24S-hydroxycholesterol (24OHC) and Tau are produced in neuronal cells and neurodegeneration leads to increased flux of both of them into cerebrospinal fluid (CSF). In the present study, CSF levels of 24OHC and 27S-hydroxycholesterol (27OHC) along with those of Tau, P-Thr(181)-Tau and Aβ(42) were mea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Björkhem, Ingemar, Patra, Kalicharan, Boxer, Adam L., Svenningsson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137204/ https://www.ncbi.nlm.nih.gov/pubmed/30245667 http://dx.doi.org/10.3389/fneur.2018.00756

Ejemplares similares

Tau Isoform-Driven CBD Pathology Transmission in Oligodendrocytes in Humanized Tau Mice
por: Zareba-Paslawska, Justyna, et al.
Publicado: (2021)

Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
por: Dolatshahi, Mahsa, et al.
Publicado: (2018)

A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid
por: Sidhu, Rohini, et al.
Publicado: (2015)

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
por: Schröder, Jens B., et al.
Publicado: (2018)

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers
por: Vasilevskaya, Anna, et al.
Publicado: (2020)

Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
por: Delaby, Constance, et al.
Publicado: (2022)

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid
por: Boman, Andrea, et al.
Publicado: (2016)

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
por: Beyer, Leonie, et al.
Publicado: (2018)

Creutzfeldt–Jakob Disease: An Unusual Presentation of Corticobasal Syndrome
por: Gosden, Grant P, et al.
Publicado: (2020)

Comparison of Ventricular and Lumbar Cerebrospinal Fluid Composition
por: Podkovik, Stacey, et al.
Publicado: (2020)

Clinical Correlates of Alzheimer's Disease Cerebrospinal Fluid Analytes in Primary Progressive Aphasia
por: Norise, Catherine, et al.
Publicado: (2019)

Regulation of Th17/Treg Balance by 27-Hydroxycholesterol and 24S-Hydroxycholesterol Correlates with Learning and Memory Ability in Mice
por: Wang, Tao, et al.
Publicado: (2022)

GRP78 Level Is Altered in the Brain, but Not in Plasma or Cerebrospinal Fluid in Parkinson’s Disease Patients
por: Baek, Jean-Ha, et al.
Publicado: (2019)

Corticobasal syndrome and Parkinson’s disease at the beginning: asymmetrical patterns of MRI and Blink Reflex for early diagnosis
por: Donzuso, Giulia, et al.
Publicado: (2022)

Novel tau filament fold in corticobasal degeneration
por: Zhang, Wenjuan, et al.
Publicado: (2020)

Sex difference in flux of 27‐hydroxycholesterol into the brain
por: Parrado‐Fernandez, Cristina, et al.
Publicado: (2021)

Quantitative detection of free 24S-hydroxycholesterol, and 27-hydroxycholesterol from human serum
por: Bandaru, Veera Venkata Ratnam, et al.
Publicado: (2014)

Tau Pathology in Parkinson's Disease
por: Zhang, Xue, et al.
Publicado: (2018)

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
por: Bluett, Brent, et al.
Publicado: (2021)

Cerebrospinal Fluid TNF-α and Orexin in Patients With Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder
por: Yuan, Yuan, et al.
Publicado: (2022)

Correlation between blood glucose and cerebrospinal fluid glucose levels in patients with differences in glucose metabolism
por: Tan, Qing Che, et al.
Publicado: (2023)

Ventriculoperitoneal Shunt Treatment Increases 7 Alpha Hy-Droxy-3-Oxo-4-Cholestenoic Acid and 24-Hydroxycholesterol Concentrations in Idiopathic Normal Pressure Hydrocephalus
por: Porru, Emanuele, et al.
Publicado: (2022)

Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics
por: Bönig, Lena, et al.
Publicado: (2019)

The Influence of Blood Contamination on Cerebrospinal Fluid Diagnostics
por: Schwenkenbecher, Philipp, et al.
Publicado: (2019)

Cerebrospinal fluid dynamics along the optic nerve
por: Sheng, Jinqiao, et al.
Publicado: (2022)

Hyperkinesias and Echolalia in Primary Familial Brain Calcification
por: Paucar, Martin, et al.
Publicado: (2020)

Corrigendum: Correlation between blood glucose and cerebrospinal fluid glucose levels in patients with differences in glucose metabolism
por: Tan, Qing Che, et al.
Publicado: (2023)

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder
por: Svenningsson, Per, et al.
Publicado: (2017)

Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson’s disease: protocol for a systematic review and individual participant data meta-analysis
por: Eusebi, Paolo, et al.
Publicado: (2017)

Editorial: Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development
por: Bougea, Anastasia, et al.
Publicado: (2023)

Caregiver strain in progressive supranuclear palsy and corticobasal syndromes
por: Kellermair, Lukas, et al.
Publicado: (2021)

Perioptic Cerebrospinal Fluid Dynamics in Idiopathic Intracranial Hypertension
por: Pircher, Achmed, et al.
Publicado: (2018)

Next-Generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Neurocysticercosis
por: Fan, Siyuan, et al.
Publicado: (2018)

Spontaneous Cerebrospinal Fluid Rhinorrhea: A Case Report
por: Boppana, Hemanth Krishna, et al.
Publicado: (2020)

Cerebrospinal Fluid Hypovolemia and Posterior Reversible Encephalopathy Syndrome
por: Zheng, Yuan-yuan, et al.
Publicado: (2020)

In vivo retention of (18)F-AV-1451 in corticobasal syndrome
por: Smith, Ruben, et al.
Publicado: (2017)

Cholesterol, Oxysterol, Triglyceride, and Coenzyme Q Homeostasis in ALS. Evidence against the Hypothesis That Elevated 27-Hydroxycholesterol Is a Pathogenic Factor
por: Wuolikainen, Anna, et al.
Publicado: (2014)

Tau and Amyloid-β Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters
por: Schirinzi, Tommaso, et al.
Publicado: (2022)

The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer’s Disease
por: Gamba, Paola, et al.
Publicado: (2021)

Metabolic and Structural Signatures of Speech and Language Impairment in Corticobasal Syndrome: A Multimodal PET/MRI Study
por: Parmera, Jacy Bezerra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kl245fa4v8bjl4d3504dccj7ct